These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6821814)

  • 21. Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations.
    Kataki A; Skandami V; Memos N; Nikolopoulou M; Oikonomou V; Androulis A; Konstadoulakis MM; Zografos CG
    J Neurosurg Sci; 2014 Mar; 58(1):9-15. PubMed ID: 24614787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms by which human gliomas may escape cellular immune attack.
    Gately MK; Glaser M; McCarron RM; Dick SJ; Dick MD; Mettetal RW; Kornblith PL
    Acta Neurochir (Wien); 1982; 64(3-4):175-97. PubMed ID: 6215833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors.
    Kempuraj D; Devi RS; Madhappan B; Conti P; Nazer MY; Christodoulou S; Reginald J; Suthinthirarajan N; Namasivayam A
    Int J Immunopathol Pharmacol; 2004; 17(1):57-64. PubMed ID: 15000867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of circulating immune complexes associated with brain tumors. Correlation with histological differentiation and length of clinical history.
    Lauro GM; Grossi M; Di Lorenzo N
    Eur Neurol; 1983; 22(5):307-13. PubMed ID: 6628459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas.
    Elliott L; Brooks W; Roszman T
    J Natl Cancer Inst; 1987 May; 78(5):919-22. PubMed ID: 3106694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.
    Jachimczak P; Bogdahn U; Schneider J; Behl C; Meixensberger J; Apfel R; Dörries R; Schlingensiepen KH; Brysch W
    J Neurosurg; 1993 Jun; 78(6):944-51. PubMed ID: 8487077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Humoral and cellular immunity in patients with left- and right-sided intracerebral tumors].
    Lisianyĭ NI; Markova OV; Prikhodchenko IA; Primushko LI
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):33-5. PubMed ID: 2787570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in the cellular immune response of patients with cerebral glioma, benign intracranial tumour, and spontaneous subarachnoid haemorrhage measured in vitro by the leucocyte migration inhibition test.
    Bean JR; Darling JL; Hoyle NR; Arigbabu SO; Thomas DG
    Neurol Res; 1983; 5(1):61-75. PubMed ID: 6140656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: Impaired cell-mediated immunity in human brain tumours.
    Thomas DG; Lannigan CB; Behan PO
    Lancet; 1975 Jun; 1(7921):1389-90. PubMed ID: 48983
    [No Abstract]   [Full Text] [Related]  

  • 30. Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression.
    Wodarz N; Rupprecht R; Kornhuber J; Schmitz B; Wild K; Braner HU; Riederer P
    J Affect Disord; 1991 Aug; 22(4):241-8. PubMed ID: 1658104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitogenic lectin receptors of nervous system tumors. Study of gliomas, neural crest tumors, and meningiomas in vitro using phytohemagglutinin and concanavalin A.
    Liwnicz BH
    J Neuropathol Exp Neurol; 1982 May; 41(3):281-97. PubMed ID: 6281395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.
    Mahaley MS; Brooks WH; Roszman TL; Bigner DD; Dudka L; Richardson S
    J Neurosurg; 1977 Apr; 46(4):467-76. PubMed ID: 191575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A sequential scanning of the immune efficiency in astrocytoma (Grade I to Grade Iii), meningioma and secondary glioma patients with and without therapeutic scheduling.
    Bhattacharjee M; Bose I; Sarkar P; Banerjee C; Dutta S; Ghosh A; Mukherjee J; Acharya S; Goswami S; Mazumdar A; Chaudhuri S; Chaudhuri S
    Cancer Invest; 2006; 24(5):502-13. PubMed ID: 16939959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
    Elliott LH; Brooks WH; Roszman TL
    J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity to normal brain antigens of blood lymphocytes from patients with gliomas.
    Wahlström T
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):763-7. PubMed ID: 4521971
    [No Abstract]   [Full Text] [Related]  

  • 36. Lymphocyte stimulation by autologous tumor cells in the presence of serum from the same patient or from healthy donors.
    Vánky F; Klein E; Stjernswärd J; Trempe G
    Int J Cancer; 1975 Nov; 16(5):850-60. PubMed ID: 1058840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-bound antiglial immunity in patients with malignant tumors of the brain.
    Wahlström T; Saksela E; Troupp H
    Cell Immunol; 1973 Feb; 6(2):161-70. PubMed ID: 4348395
    [No Abstract]   [Full Text] [Related]  

  • 38. Serological analysis of tumor antigens in malignant glioma patients.
    Yoshida S; Tanaka R; Ono K
    Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of tumor specific immunological response in the patients with malignant brain tumors by the mixed lymphocyte-tumor cell reaction].
    Yoshida S; Takai N; Ono K; Saito T; Tanaka R
    No To Shinkei; 1988 Nov; 40(11):1067-73. PubMed ID: 2975495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of tumors specific humoral anitbody against brain tumors (author'stransl)].
    Shimizu T; Kito K; Kubota S; Kitamura K; Takakura K
    No Shinkei Geka; 1974; 2(11-12):747-56. PubMed ID: 4376831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.